Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 8,124	$ 33,087
Accounts receivable, net	32,820	38,378
Other receivables	3,421	4,161
Inventories, net	4,265	20,021
Other current assets	3,186	2,990
Total current assets	51,816	98,637
Property and equipment, net	4,728	6,713
Intangible assets, net	6,862	17,575
Long-term deferred tax assets, net	787	1,117
Other assets	1,836	4,143
Total assets	66,029	128,185
Current liabilities:
Accounts payable	18,297	20,805
Accrued wages and bonuses	3,711	6,572
Deferred revenue	4,200	5,715
Line of credit	16,000	25,000
Other accrued liabilities	10,405	7,571
Total current liabilities	52,613	65,663
Long-term liabilities:
Other long-term liabilities	6,866	5,966
Total long-term liabilities	6,866	5,966
Total liabilities	59,479	71,629
Commitments and contingencies (Note 13)
Shareholders’ equity:
Preferred stock — $0.01 par value, 5,664 shares authorized; none issued or outstanding at December 31, 2017 and December 31, 2016	0	0
Common stock — no par value, 100,000 shares authorized; 39,280 and 38,521 shares issued and outstanding at December 31, 2017 and December 31, 2016	342,219	339,715
Accumulated deficit	(336,182)	(281,600)
Accumulated other comprehensive income (loss):
Cumulative translation adjustments	690	(1,032)
Unrealized loss on hedge instruments	(177)	(527)
Total accumulated other comprehensive income (loss)	513	(1,559)
Total shareholders’ equity	6,550	56,556
Total liabilities and shareholders’ equity	$ 66,029	$ 128,185